Technical analysis of None (ALLR): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific companion diagnostics, aiming to identify which patients will best respond to their various oncology therapeutics.
Price Performance
| 1 month | -14.07% |
| 3 months | -18.88% |
| Year-to-date | +7.41% |
| 1 year | -21.09% |
| 3 years | -99.78% |
52-Week Range
| 52-week High | $1.84 |
| 52-week Low | $0.77 |
| Avg Volume (90d) | 143K |
Technical Indicators
| SMA 50 | $1.29 |
| SMA 200 | $1.24 |
| Beta | 0.01 |
| 30-day Volatility (annualised) | 54.7% |
| Price vs SMA 50 | -10.0% |
| Price vs SMA 200 | -6.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|---|---|
| 2025-10 | $1.45 | |
| 2025-11 | $1.33 | -8.3% |
| 2025-12 | $1.08 | -18.8% |
| 2026-01 | $1.00 | -7.4% |
| 2026-02 | $0.97 | -3.0% |
| 2026-03 | $1.09 | +12.4% |
| 2026-04 | $1.35 | +23.9% |
| 2026-05 | $1.64 | +21.5% |
| 2026-06 | $1.29 | -21.3% |
| 2026-07 | $1.21 | -6.2% |
| 2026-08 | $1.41 | +16.5% |
| 2026-09 | $1.16 | -17.7% |
Financial Health
| Piotroski F-Score | 4 |
| Altman Z-Score | -10.51 |
Related companies: BCTX · CASI · CING · CLSD · CRIS · ENTO · KAPA
More sections of ALLR: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks